133 related articles for article (PubMed ID: 37088804)
21. A practical screening strategy for Lynch syndrome and Lynch syndrome mimics in colorectal cancer.
Yao ZG; Lv BB; Jing HY; Su WJ; Li JM; Fan H; Zhao MQ; Qin YJ; Sun XC
J Cancer Res Ther; 2021 Jul; 17(3):790-796. PubMed ID: 34269315
[TBL] [Abstract][Full Text] [Related]
22. Germline biallelic Mcm8 variants are associated with early-onset Lynch-like syndrome.
Golubicki M; Bonjoch L; Acuña-Ochoa JG; Díaz-Gay M; Muñoz J; Cuatrecasas M; Ocaña T; Iseas S; Mendez G; Cisterna D; Schubert SA; Nielsen M; van Wezel T; Goldberg Y; Pikarsky E; Robbio J; Roca E; Castells A; Balaguer F; Antelo M; Castellví-Bel S
JCI Insight; 2020 Sep; 5(18):. PubMed ID: 32841224
[TBL] [Abstract][Full Text] [Related]
23. Genetic/Familial High-Risk Assessment: Colorectal Version 1.2016, NCCN Clinical Practice Guidelines in Oncology.
Provenzale D; Gupta S; Ahnen DJ; Bray T; Cannon JA; Cooper G; David DS; Early DS; Erwin D; Ford JM; Giardiello FM; Grady W; Halverson AL; Hamilton SR; Hampel H; Ismail MK; Klapman JB; Larson DW; Lazenby AJ; Lynch PM; Mayer RJ; Ness RM; Regenbogen SE; Samadder NJ; Shike M; Steinbach G; Weinberg D; Dwyer M; Darlow S
J Natl Compr Canc Netw; 2016 Aug; 14(8):1010-30. PubMed ID: 27496117
[TBL] [Abstract][Full Text] [Related]
24. The proportion of endometrial tumours associated with Lynch syndrome (PETALS): A prospective cross-sectional study.
Ryan NAJ; McMahon R; Tobi S; Snowsill T; Esquibel S; Wallace AJ; Bunstone S; Bowers N; Mosneag IE; Kitson SJ; O'Flynn H; Ramchander NC; Sivalingam VN; Frayling IM; Bolton J; McVey RJ; Evans DG; Crosbie EJ
PLoS Med; 2020 Sep; 17(9):e1003263. PubMed ID: 32941469
[TBL] [Abstract][Full Text] [Related]
25. Implication of DNA repair genes in Lynch-like syndrome.
Xicola RM; Clark JR; Carroll T; Alvikas J; Marwaha P; Regan MR; Lopez-Giraldez F; Choi J; Emmadi R; Alagiozian-Angelova V; Kupfer SS; Ellis NA; Llor X
Fam Cancer; 2019 Jul; 18(3):331-342. PubMed ID: 30989425
[TBL] [Abstract][Full Text] [Related]
26. A novel POLD1 pathogenic variant identified in two families with a cancer spectrum mimicking Lynch syndrome.
Legrand C; Lebrun M; Naïbo P; Peysselon M; Prieur F; Kientz C; Desseigne F; Handallou S; Rey JM; Nambot S; Goussot V; Hamzaoui N; Wang Q
Eur J Med Genet; 2022 Feb; 65(2):104409. PubMed ID: 34954152
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathological and molecular characterization of Brazilian families at risk for Lynch syndrome.
de Paula AE; Galvão HCR; Bonatelli M; Sabato C; Fernandes GC; Berardinelli GN; Andrade CEM; Neto MC; Romagnolo LGC; Campacci N; Scapulatempo-Neto C; Reis RM; Palmero EI
Cancer Genet; 2021 Jun; 254-255():82-91. PubMed ID: 33647816
[TBL] [Abstract][Full Text] [Related]
28. Comparison of universal screening in major lynch-associated tumors: a systematic review of literature.
Kunnackal John G; Das Villgran V; Caufield-Noll C; Giardiello FM
Fam Cancer; 2022 Jan; 21(1):57-67. PubMed ID: 33426601
[TBL] [Abstract][Full Text] [Related]
29. Double somatic mismatch repair gene pathogenic variants as common as Lynch syndrome among endometrial cancer patients.
Hampel H; Pearlman R; de la Chapelle A; Pritchard CC; Zhao W; Jones D; Yilmaz A; Chen W; Frankel WL; Suarez AA; Cosgrove C; Backes F; Copeland L; Fowler J; O'Malley D; Salani R; McElroy JP; Stanich PP; Goodfellow P; Cohn DE
Gynecol Oncol; 2021 Jan; 160(1):161-168. PubMed ID: 33393477
[TBL] [Abstract][Full Text] [Related]
30. Comparison of screening strategies for Lynch syndrome in patients with newly diagnosed endometrial cancer: a prospective cohort study in China.
Chao X; Li L; Wu M; Ma S; Tan X; Zhong S; Bi Y; Lang J
Cancer Commun (Lond); 2019 Jul; 39(1):42. PubMed ID: 31307542
[TBL] [Abstract][Full Text] [Related]
31. The implications of BRCA loss of heterozygosity (LOH) and deficient mismatch repair gene (dMMR) expression in the breast cancer of a patient with both inherited breast and ovarian cancer syndrome (BRCA2) and Lynch syndrome (MLH1).
Sorscher S; Ansley K; Delaney SD; Ramkissoon S
Breast Cancer Res Treat; 2020 Apr; 180(2):511-514. PubMed ID: 32040686
[TBL] [Abstract][Full Text] [Related]
32. Universal screening for Lynch syndrome in a large consecutive cohort of Chinese colorectal cancer patients: High prevalence and unique molecular features.
Jiang W; Cai MY; Li SY; Bei JX; Wang F; Hampel H; Ling YH; Frayling IM; Sinicrope FA; Rodriguez-Bigas MA; Dignam JJ; Kerr DJ; Rosell R; Mao M; Li JB; Guo YM; Wu XY; Kong LH; Tang JH; Wu XD; Li CF; Chen JR; Ou QJ; Ye MZ; Guo FM; Han P; Wang QW; Wan DS; Li L; Xu RH; Pan ZZ; Ding PR;
Int J Cancer; 2019 May; 144(9):2161-2168. PubMed ID: 30521064
[TBL] [Abstract][Full Text] [Related]
33. Variation in the risk of colorectal cancer in families with Lynch syndrome: a retrospective cohort study.
International Mismatch Repair Consortium
Lancet Oncol; 2021 Jul; 22(7):1014-1022. PubMed ID: 34111421
[TBL] [Abstract][Full Text] [Related]
34. Screening for Lynch syndrome in young Saudi colorectal cancer patients using microsatellite instability testing and next generation sequencing.
Alqahtani M; Edwards C; Buzzacott N; Carpenter K; Alsaleh K; Alsheikh A; Abozeed W; Mashhour M; Almousa A; Housawi Y; Al Hawwaj S; Iacopetta B
Fam Cancer; 2018 Apr; 17(2):197-203. PubMed ID: 28643016
[TBL] [Abstract][Full Text] [Related]
35. Identification of novel pathogenic MSH2 mutation and new DNA repair genes variants: investigation of a Tunisian Lynch syndrome family with discordant twins.
Jaballah-Gabteni A; Tounsi H; Kabbage M; Hamdi Y; Elouej S; Ben Ayed I; Medhioub M; Mahmoudi M; Dallali H; Yaiche H; Ben Jemii N; Maaloul A; Mezghani N; Abdelhak S; Hamzaoui L; Azzouz M; Boubaker S
J Transl Med; 2019 Jun; 17(1):212. PubMed ID: 31248416
[TBL] [Abstract][Full Text] [Related]
36. Detecting Lynch syndrome by pathologists.
van Krieken JH; Kets CM; Ligtenberg MJ; Hoogerbrugge N
Verh Dtsch Ges Pathol; 2007; 91():104-11. PubMed ID: 18314603
[TBL] [Abstract][Full Text] [Related]
37. Germline variant testing in serrated polyposis syndrome.
Murphy A; Solomons J; Risby P; Gabriel J; Bedenham T; Johnson M; Atkinson N; Bailey AA; Bird-Lieberman E; Leedham SJ; East JE; Biswas S
J Gastroenterol Hepatol; 2022 May; 37(5):861-869. PubMed ID: 35128723
[TBL] [Abstract][Full Text] [Related]
38. Lessons learnt from implementation of a Lynch syndrome screening program for patients with gynaecological malignancy.
Najdawi F; Crook A; Maidens J; McEvoy C; Fellowes A; Pickett J; Ho M; Nevell D; McIlroy K; Sheen A; Sioson L; Ahadi M; Turchini J; Clarkson A; Hogg R; Valmadre S; Gard G; Dooley SJ; Scott RJ; Fox SB; Field M; Gill AJ
Pathology; 2017 Aug; 49(5):457-464. PubMed ID: 28669579
[TBL] [Abstract][Full Text] [Related]
39. Extent of Pedigree Required to Screen for and Diagnose Hereditary Nonpolyposis Colorectal Cancer: Comparison of Simplified and Extended Pedigrees.
Heo Y; Kim MH; Kim DW; Lee SA; Bang S; Kim MJ; Oh HK; Kang SB; Kang SI; Park JW; Ryoo SB; Jeong SY; Park KJ
Dis Colon Rectum; 2020 Feb; 63(2):152-159. PubMed ID: 31842160
[TBL] [Abstract][Full Text] [Related]
40. Colorectal cancer screening in Lynch syndrome: Indication, techniques and future perspectives.
Perrod G; Rahmi G; Cellier C
Dig Endosc; 2021 May; 33(4):520-528. PubMed ID: 32314431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
